COLOMBO NICOLETTA

Ruolo: 
Professore associato
Settore scientifico disciplinare: 
GINECOLOGIA E OSTETRICIA (MED/40)

Pubblicazioni

  • Rizzo, S., De Piano, F., Buscarino, V., Pagan, E., Bagnardi, V., Zanagnolo, V., et al. (2020). Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study. EUROPEAN JOURNAL OF RADIOLOGY, 123, 108786. Dettaglio
  • Penson, R., Valencia, R., Cibula, D., Colombo, N., Leath, C., Bidziński, M., et al. (2020). Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial. JOURNAL OF CLINICAL ONCOLOGY, JCO1902745. Dettaglio
  • Gori, S., Barberis, M., Bella, M., Buttitta, F., Capoluongo, E., Carrera, P., et al. (2019). Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 140, 67-72. Dettaglio
  • Tomao, F., Bardhi, E., Di Pinto, A., Sassu, C., Biagioli, E., Petrella, M., et al. (2019). Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status. CANCER TREATMENT REVIEWS, 80. Dettaglio
  • Lorusso, D., Hilpert, F., Gonzalez Martin, A., Rau, J., Ottevanger, P., Greimel, E., et al. (2019). Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 29(7), 1141-1147. Dettaglio